Prevalence and Medications of Atopic Dermatitis in Germany: Claims Data Analysis.

Background: Information on the prevalence of atopic dermatitis (AD) varies greatly, and so far, only a few studies describe the healthcare of patients with AD in Germany.

Objective: The aim of the study is to describe the prevalence and medications of people with AD in Germany.

Methods: Health insurance data for the year 2019 were examined.

Laboratory investigations of vaccinated patients with varicella.

Background: Accompanying varicella vaccination in children in Germany recommended with one (2004) and two (2009) doses, sentinel surveillance of varicella with a sample (n∼900) of private physicians was established in 2005. Physicians reported monthly aggregated data on all varicella cases and case-based on vaccinated patients, of whom skin lesion samples were laboratory investigated to identify varicella-zoster virus (VZV). We analyzed the impact of vaccination frequency on the number of cases and on laboratory results within the sentinel.

Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.

In Germany, one dose of varicella vaccination has been recommended for children aged <24 months since 2004, and 2 doses have been recommended since 2009. Vaccination coverage (VC) is above 80% for one dose and 60% for 2 doses. In this study, data on varicella- and shingles-associated hospitalizations before and after vaccine introduction were assessed.